v2.2
Contact
News
Diagnosing DIRD
Browse
Available on AppStore
The Drug-Induced Respiratory Disease Website
Philippe Camus, M.D.
Dijon, France
Browse by »
Drugs
Patterns
Etanercept
4
XV.e
Path: ILD with a granulomatous component (see also Im)
2
Last update :
07/10/2012
Search
Search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
TNF-alpha antagonists / inhibitors
Publications
Pulmonary Sarcoidosis following Etanercept Treatment.
Development of sarcoidosis during etanercept therapy.
Pulmonary lymphohistiocytic reactions temporally related to etanercept therapy.
Lung injury linked to etanercept therapy.